深圳市福瑞康科技

Shenzhen Furuikang Technology is a Chinese medical technology company founded in 2018 that specializes in the diagnosis of Helicobacter pylori (Hp) infections. The company has developed and commercialized the GP1000 Helicobacter pylori tester and its matching collection cards, which utilize advanced solid-state scintillation detection technology to provide safe, efficient, and non-toxic breath testing. In addition to medical devices, Furuikang is expanding into diagnostic pharmaceuticals, with its Urea [14C] Capsule receiving IND acceptance in China in early 2026. The company is also actively developing Urea [13C] diagnostic drugs and automated testing equipment to establish a comprehensive portfolio in the breath diagnostics market.